Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Martnez-Fernndez L, Gonzlez-Muniesa P, Laiglesia LM, Sinz N, Prieto-Hontoria PL, Escot X, et al
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro, and for chronic weight management as Zepbound
Bkdal TA, Thomsen M, Kupov V, et al
Glutathione-capped fluorescent gold nanoclusters for dual-modal fluorescence/X-ray computed tomography imaging
Anyone who has obtained written clarification on the 90-day guarantee terms and understands what the published refund policy covers
BMJ Open Diabetes Res Care 8(1)
US$ 28.46
US$ 28.50
US$ 22.66
US$ 24.91
US$ 20.36
US$ 28.23
US$ 20.76
US$ 28.47
